Market Research Industry Reports

Savara Inc (SVRA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The companys lead product candidates include Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of treatment of PAP; and AeroVanc, an inhaled formulation of vancomycin for the treatment of CF. Its development pipeline also includes Aironite, a sodium nitrite solution for intermittent inhalation for the treatment of heart failure. The company has subsidiaries in the US and Denmark. Savara is headquartered in Austin, Texas, the US.

Savara Inc (SVRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Savara Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Savara Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Savara Inc, Medical Devices Deals, 2012 to YTD 2018 10
Savara Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Savara Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Savara Pharma Raises USD20 Million in Series C Financing Round 12
Savara Pharmaceuticals Secures USD18.54 Million in Venture Funding 13
Savara Pharma Raises Additional USD5.5 Million in Financing Round 14
Savara Pharma Raises USD4.5 Million in Financing Round 15
Savara Pharma Raises US$14 Million In Series B Financing 16
Partnerships 17
Aires Pharma Enters into Agreement with University of Pittsburgh 17
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 18
Merger 19
Mast Therapeutics Merges with Savara 19
Licensing Agreements 21
NobelPharma Enters into Licensing Agreement with Savara 21
NobelPharma Enters into Licensing Agreement with Serendex Pharma 22
Equity Offering 23
Savara Plans to Raise up to USD250 Million in Public Offering of Securities 23
Savara Prices Public Offering of Shares for USD47.3 Million 24
Savara Raises USD42.9 Million in Public Offering of Shares 26
Savara to Raise up to USD18 Million in Public Offering of Shares 27
Savara Raises USD8 Million in Public Offering of Shares and Warrants 28
Serendex Pharma Raises USD12.7 Million Rights Offering of Shares 29
Savara Raises USD21 Million in Public Offering of Shares and Warrants 31
Savara Raises USD0.9 Million in Public Offering of Shares up on Exercise of Warrants 32
Serendex Pharma Completes IPO for USD11 Million 33
Savara Raises USD30 Million in Public Offering of Shares 35
Acquisition 36
Savara Pharma Acquires Serendex Pharma 36
Mast Therapeutics Completes Acquisition Of Aires Pharma 37
Savara Inc - Key Competitors 38
Savara Inc - Key Employees 39
Savara Inc - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Financial Announcements 41
May 09, 2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update 41
Mar 14, 2018: Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update 43
Nov 08, 2017: Savara Reports Third Quarter 2017 Financial Results and Provides Business Update 45
Aug 09, 2017: Savara Reports Second Quarter 2017 Financial Results and Provides Business Update 46
Product News 47
03/06/2017: Mast Therapeutics Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients 47
Clinical Trials 48
May 10, 2017: Savara Announces Expedited U.S. Molgradex Development Strategy 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables

List of Tables
Savara Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Savara Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Savara Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Savara Inc, Medical Devices Deals, 2012 to YTD 2018 10
Savara Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Savara Pharma Raises USD20 Million in Series C Financing Round 12
Savara Pharmaceuticals Secures USD18.54 Million in Venture Funding 13
Savara Pharma Raises Additional USD5.5 Million in Financing Round 14
Savara Pharma Raises USD4.5 Million in Financing Round 15
Savara Pharma Raises US$14 Million In Series B Financing 16
Aires Pharma Enters into Agreement with University of Pittsburgh 17
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 18
Mast Therapeutics Merges with Savara 19
NobelPharma Enters into Licensing Agreement with Savara 21
NobelPharma Enters into Licensing Agreement with Serendex Pharma 22
Savara Plans to Raise up to USD250 Million in Public Offering of Securities 23
Savara Prices Public Offering of Shares for USD47.3 Million 24
Savara Raises USD42.9 Million in Public Offering of Shares 26
Savara to Raise up to USD18 Million in Public Offering of Shares 27
Savara Raises USD8 Million in Public Offering of Shares and Warrants 28
Serendex Pharma Raises USD12.7 Million Rights Offering of Shares 29
Savara Raises USD21 Million in Public Offering of Shares and Warrants 31
Savara Raises USD0.9 Million in Public Offering of Shares up on Exercise of Warrants 32
Serendex Pharma Completes IPO for USD11 Million 33
Savara Raises USD30 Million in Public Offering of Shares 35
Savara Pharma Acquires Serendex Pharma 36
Mast Therapeutics Completes Acquisition Of Aires Pharma 37
Savara Inc, Key Competitors 38
Savara Inc, Key Employees 39
Savara Inc, Subsidiaries 40

List Of Figures

List of Figures
Savara Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Savara Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Savara Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Savara Inc, Medical Devices Deals, 2012 to YTD 2018 10

Savara Inc (SVRA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar

USD 250View Report

Savara Inc (SVRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Savara Inc. (Savara) formerly Mast Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar

USD 250View Report

Savara Inc (SVRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Savara Inc. (Savara) formerly Mast Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar

USD 250View Report

Savara Inc (SVRA) - Medical Equipment - Deals and Alliances Profile

Savara Inc. (Savara) formerly Mast Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2018
No. of Pages :49
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube